Takeda Incoming President To Redo Management System
This article was originally published in PharmAsia News
Executive SummaryTakeda's Yasuchika Hasegawa, slated to become new CEO in June, says he plans to remake the company's management system. Among his changes, Hasegawa plans to divide decision-making among three executives, one each for research and development, overseas marketing and management supervision. He said his three top executives would head the three parts. Hasegawa is slated to replace Kunio Takeda, a member of the founding family, who has been president and chairman for the past 16 years. (Click here for more - a subscription may be required
You may also be interested in...
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.